Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Pharmaceuticals ETF

107.40
+0.60000.56%
Volume:70.10K
Turnover:7.54M
Market Cap:1.75B
PE:10.00
High:107.94
Open:107.39
Low:106.93
Close:106.80
52wk High:108.66
52wk Low:69.02
Shares:16.30M
Float Shares:16.30M
Volume Ratio:0.35
T/O Rate:0.43%
Dividend:1.46
Dividend Rate:1.36%
EPS(TTM):10.74
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Dow up 136 Points on Gains for Shares of Merck, Goldman Sachs

Dow Jones
·
16 mins ago

Eli Lilly Stock (LLY) Rattled as Companies Decline to Cover Weight-Loss Drug Costs

TIPRANKS
·
20 mins ago

Merck & Co Inc Stock (MRK) Moved Up by 3.76% on Aug 25: A Full Analysis

TradingKey
·
44 mins ago

Bristol Myers Squibb Stock (BMY) Looks Healthier After Ditching Blood Cancer Partner

TIPRANKS
·
46 mins ago

More US Employers to Drop Weight-Loss Drugs in 2027, as Healthcare Costs Increase

Reuters
·
56 mins ago

Lilly’s LY4395089 Interaction Study Marks Quiet but Important Early-Stage Progress

TIPRANKS
·
2 hours ago

Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck

TIPRANKS
·
2 hours ago

Confirm That We Have Ended Our Partnership with Cellares. - Bristol Myers Spokesperson

THOMSON REUTERS
·
Yesterday

Bristol Myers Spokesperson: Determined Cellares-Partnered Cell Shuttle System Could not Meet Necessary Requirements to Make Commercial Breyanzi

THOMSON REUTERS
·
Yesterday

FDA Greenlights Roche and Eli Lilly's Blood-Based Alzheimer's Test, Setting a Single Threshold to Rule Both In and Out Amyloid Pathology

Deep News
·
Yesterday

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Yesterday

Merck Price Target Raised to $170.00/Share from $145.00 by Argus Research

Dow Jones
·
Yesterday

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

Dow Jones
·
Yesterday

Merck & Company (MRK) Gets a Buy from Scotiabank

TIPRANKS
·
Yesterday

Merck price target raised to $170 from $145 at Argus

TIPRANKS
·
Yesterday

Parabilis Medicines Appoints Former J&J Oncology Executive Craig Tendler to Board

Reuters
·
Yesterday

Merck price target raised to $180 from $155 at Wolfe Research

TIPRANKS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Eli Lilly & Co (LLY)

TIPRANKS
·
Yesterday

Merck (MRK) Stock May Be 35% Undervalued After Cancer Vaccine Data

Simply Wall St.
·
Yesterday

US FDA Expands Approval for J&J's Drug for Rare Blood Disorder

Reuters
·
Yesterday